Back

Factor XI inhibition – other indications: acute coronary syndrome, venous thromboembolism

16 April 2023 (15:15 - 15:30)
Organised by:
Congress Presentation Part of: The new frontier in oral anticoagulation: Factor XIa inhibitors Stroke Prevention EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Davide Capodanno

University of Catania, Catania (Italy)

4 More presentations in this session

Presentation thumbnail
This programme is supported by Bayer Pharma AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor
Slides
Presentation thumbnail
Non-vitamin K antagonist oral anticoagulants (NOACs) – Limitations and new opportunities
Professor J. Steffel (Zurich, CH)
Slides Video
Presentation thumbnail
Factor XI inhibition – are NOACs obsolete? Mechanistic and pharmacological insights
Doctor J. Weitz (Hamilton, CA)
Slides Video
Presentation thumbnail
Factor XI inhibition – the new paradigm for atrial fibrillation and stroke
Professor G. Lip (Liverpool, GB)
Slides Video

Access the full session

Session thumbnail
The new frontier in oral anticoagulation: Factor XIa inhibitors
Video

The Event

Event poster

EHRA 2023

16 April 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Shaping clinical practice and clinical trials
29 August 2025
thumbnail
Congress Presentation
Injectable antiplatelet therapies: what's new?
20 March 2026
thumbnail
Congress Session
From bench to bedside: how changes in the data landscape have shaped venous thromboembolism treatment as well as prevention of recurrence
26 August 2023
thumbnail
Congress Presentation
Factor XI inhibitors in early clinical trials: a meta-analysis
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources